Stanford Letter or Traditional Advance Directive in Advance Care Planning

Status Completed

Clinical Trial Summary

The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive. Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.

Clinical Trial Description

PRIMARY OBJECTIVES I. To compare advance care planning (ACP) completion rate amongst bone marrow transplant (BMT) recipients receiving the Stanford Letter versus the traditional advance directive (AD) through a prospective, pilot randomized controlled trial (RCT). SECONDARY OBJECTIVES: I. To evaluate differences in patient preference for choice to prolong life following completion of the ACP tool in each group. II. To assess uncertainty with decision making regarding end of life care following completion of the ACP tool in each group. III. To explore patient understanding of and satisfaction with the ACP tool in each group. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I (INTERVENTION): Patients listen to a dialogue on the purpose of ACP. Patients receive a paper copy and online web link to the Stanford Letter and complete and return the form by the day of BMT. After completion of the Stanford Letter, patients undergo a semi-structured, research staff-led interview to evaluate personal perceptions of uncertainty with end-of-life decisions, understanding of the ACP form received, and satisfaction with the ACP form. GROUP II (CONTROL): Patients listen to a dialogue on the purpose of ACP. Patients receive a paper copy and online web link to the California (CA) Advance Health Care Directive Form and complete and return the form by the day of BMT. After completion of the CA Advance Health Care Directive Form, patients undergo interview as in Group I. After completion of study, patients are followed up periodically. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03028961
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	March 3, 2017
Completion date	July 27, 2021

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02451462` - Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients	N/A
Completed	`NCT03654599` - Effects of Digital Stories Intervention on Psychosocial Well-being	N/A
Active, not recruiting	`NCT04395222` - Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation	Phase 2
Not yet recruiting	`NCT05603156` - A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive	N/A
Completed	`NCT03530969` - Geriatric Communication Skills Training Program for Oncology Clinicians	N/A
Recruiting	`NCT04115241` - Activity Levels in Bone Marrow Transplant Patients
Completed	`NCT00143780` - Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination	Phase 4
Completed	`NCT05662631` - Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients	N/A
Completed	`NCT02575079` - Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT	N/A
Active, not recruiting	`NCT02665065` - Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia	Phase 3
Completed	`NCT01735565` - Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant	N/A
Completed	`NCT04041219` - Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients	Phase 4
Not yet recruiting	`NCT06361173` - Spanish BMT4me Usability & Acceptability
Completed	`NCT03030248` - Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients	Phase 2
Completed	`NCT00695123` - Screening for Subjects to Participate in Studies of Blood Disorders
Terminated	`NCT02057289` - A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis	Phase 1
Completed	`NCT04275830` - The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients	N/A
Completed	`NCT03902210` - BMT Online Wellness Study	N/A
Completed	`NCT03245788` - Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study	N/A
Completed	`NCT03758911` - Perspectives on Bone Marrow Donors Who Donate for Their Parent

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant — BMTSLPRCT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms